Literature DB >> 19091426

Plasma concentrations of endotoxin and platelet activation in the developmental stage of oligofructose-induced laminitis.

S R Bailey1, H S Adair, C R Reinemeyer, S J Morgan, A C Brooks, S L Longhofer, J Elliott.   

Abstract

The link between the fermentation of carbohydrate in the equine large intestine and the development of acute laminitis is poorly understood. Absorption of endotoxin (lipopolysaccharide; LPS) into the plasma has been observed in one experimental model of laminitis, but does not cause laminitis when administered alone. Thus, the potential role of endotoxin is unclear. Platelet activation has previously been demonstrated in the developmental stage of laminitis. Equine platelets are more sensitive than leukocytes to activation by endotoxin, and can be activated directly by LPS in the low pg/ml range, activating p38 MAP kinase and releasing serotonin (5-HT) and thromboxane. The objectives of this study were firstly to determine whether endotoxin and platelet activation could be measured in the plasma of horses in the developmental phase of laminitis induced with oligofructose. Secondly, the time course of events involving platelet activation and platelet-derived vasoactive mediator production was investigated. Laminitis was induced in six Standardbred horses by the administration of 10 g/kg bwt of oligofructose. Plasma samples were obtained every 4h, and platelet pellets were obtained by centrifugation. LPS was measured using a kinetic limulus amebocyte lysate assay, and platelet activation was assessed by Western blotting for the phosphorylated form of p38 MAP kinase. Plasma 5-HT was assayed by HPLC with electrochemical detection and thromboxane B(2) was measured by radioimmunoassay. Clinical signs of laminitis and histopathologic changes were observed in lamellar sections from five of the six horses. Onset of lameness was between 20 and 30 h after the administration of oligofructose. LPS increased above the limit of detection (0.6 pg/ml) to reach a peak of 2.4+/-1.0 pg/ml at 8 h. TNFalpha was also detectable in the plasma from 12 to 24 h. There was a time-dependent increase in platelet p38 MAPK phosphorylation, which peaked at approximately 12 h (3.8+/-1.3 fold increase); plasma 5-HT and thromboxane increased steadily after this time (2.9+/-0.6 and 11.3+/-5.0 fold increases, respectively). These data indicate that small quantities of endotoxin may move into the circulation from the large intestine after the sharp decrease in pH that occurs as a result of carbohydrate fermentation. Correlating these findings with in vitro studies suggests that LPS may primarily activate platelets, leading indirectly to the activation of leukocytes. Therefore, endotoxin may contribute in the initiation of the early inflammatory changes observed in experimental models of acute laminitis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19091426     DOI: 10.1016/j.vetimm.2008.11.009

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  11 in total

1.  Use of laser capture microdissection for the assessment of equine lamellar basal epithelial cell signalling in the early stages of laminitis.

Authors:  B S Leise; M R Watts; S Roy; A S Yilmaz; H Alder; J K Belknap
Journal:  Equine Vet J       Date:  2014-08-19       Impact factor: 2.888

2.  Fecal coagulase-negative staphylococci from horses, their species variability, and biofilm formation.

Authors:  E Bino; Andrea Lauková; J Ščerbová; I Kubašová; A Kandričáková; V Strompfová; R Miltko; G Belzecki
Journal:  Folia Microbiol (Praha)       Date:  2019-01-31       Impact factor: 2.099

3.  Identification of a core bacterial community within the large intestine of the horse.

Authors:  Kirsty Dougal; Gabriel de la Fuente; Patricia A Harris; Susan E Girdwood; Eric Pinloche; C Jamie Newbold
Journal:  PLoS One       Date:  2013-10-24       Impact factor: 3.240

4.  Milk thistle extract and silymarin inhibit lipopolysaccharide induced lamellar separation of hoof explants in vitro.

Authors:  Nicole Reisinger; Simone Schaumberger; Veronika Nagl; Sabine Hessenberger; Gerd Schatzmayr
Journal:  Toxins (Basel)       Date:  2014-10-06       Impact factor: 4.546

Review 5.  A Potential Role for Pro-Inflammatory Cytokines in the Development of Insulin Resistance in Horses.

Authors:  Jessica K Suagee; Benjamin A Corl; Raymond J Geor
Journal:  Animals (Basel)       Date:  2012-05-02       Impact factor: 2.752

6.  Evaluation of platelet-rich plasma applied in the coronary band of healthy equine hooves.

Authors:  Sarah Raphaela Torquato Seidel; Anderson Fernando de Souza; Joice Fülber; Paulo Moreira Bogossian; Nubia Nayara Pereira Rodrigues; Raquel Yvonne Arantes Baccarin
Journal:  Can Vet J       Date:  2021-07       Impact factor: 1.008

7.  An Oligosaccharide Rich Diet Increases Akkermansia spp. Bacteria in the Equine Microbiota.

Authors:  Frederikke Christine Lindenberg; Ditte Olsen Lützhøft; Lukasz Krych; James Fielden; Witold Kot; Hanne Frøkiær; Gaby van Galen; Dennis Sandris Nielsen; Axel Kornerup Hansen
Journal:  Front Microbiol       Date:  2021-05-21       Impact factor: 5.640

8.  Concentration Dependent Influence of Lipopolysaccharides on Separation of Hoof Explants and Supernatant Lactic Acid Concentration in an Ex Vivo/In Vitro Laminitis Model.

Authors:  Nicole Reisinger; Simone Schaumberger; Veronika Nagl; Sabine Hessenberger; Gerd Schatzmayr
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240

9.  An in vitro model of the horse gut microbiome enables identification of lactate-utilizing bacteria that differentially respond to starch induction.

Authors:  Amy S Biddle; Samuel J Black; Jeffrey L Blanchard
Journal:  PLoS One       Date:  2013-10-01       Impact factor: 3.240

10.  Fumonisin B₁ (FB₁) Induces Lamellar Separation and Alters Sphingolipid Metabolism of In Vitro Cultured Hoof Explants.

Authors:  Nicole Reisinger; Ilse Dohnal; Veronika Nagl; Simone Schaumberger; Gerd Schatzmayr; Elisabeth Mayer
Journal:  Toxins (Basel)       Date:  2016-03-24       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.